BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37958307)

  • 1. Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
    Lucarelli E; De Vita A; Bellotti C; Frisoni T; Vanni S; Guerrieri AN; Pannella M; Mercatali L; Gambarotti M; Duchi S; Miserocchi G; Maioli M; Liverani C; Ibrahim T
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
    Nascimento AF; Bertoni F; Fletcher CD
    Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.
    Vanni S; De Vita A; Gurrieri L; Fausti V; Miserocchi G; Spadazzi C; Liverani C; Cocchi C; Calabrese C; Bongiovanni A; Riva N; Mercatali L; Pieri F; Casadei R; Lucarelli E; Ibrahim T
    Ther Adv Med Oncol; 2022; 14():17588359221093973. PubMed ID: 35782752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review.
    Yoshimoto M; Yamada Y; Ishihara S; Kohashi K; Toda Y; Ito Y; Yamamoto H; Furue M; Nakashima Y; Oda Y
    Am J Surg Pathol; 2020 Jan; 44(1):87-97. PubMed ID: 31651522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxofibrosarcoma primary cultures: molecular and pharmacological profile.
    De Vita A; Recine F; Mercatali L; Miserocchi G; Liverani C; Spadazzi C; Casadei R; Bongiovanni A; Pieri F; Riva N; Amadori D; Ibrahim T
    Ther Adv Med Oncol; 2017 Dec; 9(12):755-767. PubMed ID: 29449896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
    Gilg MM; Sunitsch S; Leitner L; Bergovec M; Szkandera J; Leithner A; Liegl-Atzwanger B
    Orthop Traumatol Surg Res; 2020 Oct; 106(6):1059-1065. PubMed ID: 32778437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
    Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
    Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and survival factors of appendicular myxofibrosarcoma: a SEER-retrospective study.
    Dahl V; Lee Y; Rate W; Guertin MP; Pretell-Mazzini J
    Rep Pract Oncol Radiother; 2023; 28(6):711-719. PubMed ID: 38515824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma.
    Washimi K; Kasajima R; Shimizu E; Sato S; Okubo Y; Yoshioka E; Narimatsu H; Hiruma T; Katayama K; Yamaguchi R; Yamaguchi K; Furukawa Y; Miyano S; Imoto S; Yokose T; Miyagi Y
    Sci Rep; 2023 Apr; 13(1):6744. PubMed ID: 37185612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin 6 expression is useful to distinguish myxofibrosarcomas from other myxoid soft tissue tumors.
    Bekki H; Yamamoto H; Takizawa K; Iwasaki T; Otsuka H; Yamada Y; Kohashi K; Harimaya K; Iwamoto Y; Oda Y
    Pathol Res Pract; 2017 Jun; 213(6):674-679. PubMed ID: 28476380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of radio-hyperthermo-chemotherapy as salvage therapy for recurrent or residual malignant soft tissue tumors.
    Aiba H; Yamada S; Mizutani J; Yamamoto N; Okamoto H; Hayashi K; Takeuchi A; Miwa S; Higuchi T; Abe K; Taniguchi Y; Tsuchiya H; Otsuka T
    Int J Hyperthermia; 2018; 35(1):658-666. PubMed ID: 30295115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
    Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
    Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives.
    Nishio J; Nakayama S
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models.
    Guerrieri AN; Bellotti C; Penzo M; Columbaro M; Pannella M; De Vita A; Gambarotti M; Mercatali L; Laranga R; Dozza B; Vanni S; Corsini S; Frisoni T; Miserocchi G; Ibrahim T; Lucarelli E
    BMC Cancer; 2023 Dec; 23(1):1194. PubMed ID: 38057796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation.
    Mühlhofer HML; Lenze U; Gersing A; Lallinger V; Burgkart R; Obermeier A; VON Eisenhart-Rothe R; Knebel C
    Anticancer Res; 2019 Jun; 39(6):2985-2992. PubMed ID: 31177139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course].
    Mentzel T; Katenkamp D; Fletcher CD
    Pathologe; 1996 Mar; 17(2):116-21. PubMed ID: 8650138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line.
    Miserocchi G; De Vita A; Mercatali L; Recine F; Liverani C; Spadazzi C; Pieri F; Riva N; Bongiovanni A; Casadei R; Fausti V; Ibrahim T
    Cells; 2018 Oct; 7(11):. PubMed ID: 30366467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
    Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.
    Mentzel T; Brown LF; Dvorak HF; Kuhnen C; Stiller KJ; Katenkamp D; Fletcher CD
    Virchows Arch; 2001 Jan; 438(1):13-22. PubMed ID: 11213831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxofibrosarcoma of the abdominal wall : A case report and literature review.
    Beji H; Bouassida M; Chtourou MF; Zribi S; Moghri MM; Touinsi H
    Int J Surg Case Rep; 2022 Jun; 95():107275. PubMed ID: 36721186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.